On February 18, 2017, three EOHSI and CEED members were named Fellows of the American Association for the Advancement of Science (AAAS). This honor is given to AAAS members whose contributions to science are recognized as significantly advancing their discipline and contributing to society.
Ah-Ng Tony Kong, Glaxo Endowed Professor of Pharmaceutics, was recognized for his research on phytochemicals, cancer chemoprevention and epigenetics. The AAAS cited Dr. Kong for his “…distinguished contributions to the field of ….phytochemicals, Nrf2-mediated signaling, and cancer chemoprevention, as well as academic leadership at Rutgers University.”
Christopher J. Molloy, Senior Vice-President for Research and Economic Development and former Dean of the Mario School of Pharmacy, was recognized for his research in drug discovery and management in the biopharmaceutical industry, as well has his work in inflammation, carcinogenesis, and pathways regulating tissue remodeling. The AAAS cited his “…distinguished contributions to the advancement of medical sciences, particularly achievements in molecular pharmacology, drug discovery, and administrative leadership in research and economic development.”
Suzie Chen, Professor of Chemical Biology, was recognized for unraveling some of the mechanisms of melanoma development using a novel transgenic mouse model. She identified the aberrant expression of Grm 1, a G-protein-coupled glutamate receptor, as key factor in melanoma development, offering a new direction for pharmacotherapy in human disease. The AAAS cited her “…significant contributions in translational research in melanoma biology, particularly for identifying the critical role of glutamatergic signaling in the etiology of melanoma.”